United Therapeutics Corporation Board of Directors

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

Mr. Patrick Poisson

Mr. Patrick Poisson

Executive VP of Technical Operations

Dr. Leigh Peterson

Dr. Leigh Peterson

Executive Vice President of Product Development & Xenotransplantation

Mr. Paul A. Mahon J.D.

Mr. Paul A. Mahon J.D.

Executive VP, General Counsel & Corporate Secretary

Kevin T. Gray

Kevin T. Gray

Senior Vice President of Strategic Operations & Logistics

Mr. Dewey Steadman C.F.A.

Mr. Dewey Steadman C.F.A.

Head of Investor Relations

Mr. Gil Golden

Mr. Gil Golden

Senior VP & Chief Medical Officer

Ms. Holly Hobson

Ms. Holly Hobson

Associate Vice President of Human Resources

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.